![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Liver Diseases |
Free Subscription
2 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
Editorial Comment: Integrated Diagnosis of Hepatocellular Carcinoma-An
Opportunity for Abdominal Radiologists.
AJR Am J Roentgenol. 2022 May 4:12. doi: 10.2214/AJR.22.27611.
PubMed
Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel
Narrative Review.
AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27633.
PubMed
Abstract available
Additional Analyses for the Published Primary Norfloxacin Prophylaxis for
APASL-Defined Acute-on-Chronic Liver Failure.
Am J Gastroenterol. 2022;117:814-815.
PubMed
A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
Am J Gastroenterol. 2022;117:815.
PubMed
Hepatic protein and phosphoprotein signatures of alcohol-associated cirrhosis and
hepatitis.
Am J Pathol. 2022 Apr 28. pii: S0002-9440(22)00121.
PubMed
Abstract available
Circulating Tumor Cells Derived from Advanced Hepatocellular Carcinoma Rapidly
Develop Resistance to Cytotoxic Chemotherapy.
Anticancer Res. 2022;42:2479-2486.
PubMed
Abstract available
Surgical Indications for Huge Hepatocellular Carcinoma.
Anticancer Res. 2022;42:2573-2581.
PubMed
Abstract available
Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With
Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
Anticancer Res. 2022;42:2495-2505.
PubMed
Abstract available
Inhibition of NAD kinase elevates the hepatic NAD(+) pool and alleviates
acetaminophen-induced acute liver injury in mice.
Biochem Biophys Res Commun. 2022;612:70-76.
PubMed
Abstract available
Comprehensive analysis of the associations between clinical factors and outcomes
by machine learning, using post marketing surveillance data of cabazitaxel in
patients with castration-resistant prostate cancer.
BMC Cancer. 2022;22:470.
PubMed
Abstract available
Number of endoscopic sessions to eradicate varices identifies high risk of
rebleeding in cirrhotic patients.
BMC Gastroenterol. 2022;22:213.
PubMed
Abstract available
Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma:
multicentre study.
Br J Surg. 2022 May 3. pii: 6577149. doi: 10.1093.
PubMed
Abstract available
A new therapy for refractory gastric cancer bleeding: endoscopic
ultrasound-guided lauromacrogol injection.
Endoscopy. 2021 Apr 16. doi: 10.1055/a-1398-5196.
PubMed
A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
PubMed
Effects of PPIs in cirrhotic patients: What do we really know?
Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
PubMed
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform
Antifibrotic Drug Development.
Gastroenterology. 2022;162:1210-1225.
PubMed
Abstract available
Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute
Liver Failure.
Gastroenterology. 2022;162:1226-1241.
PubMed
Abstract available
Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
Gastroenterology. 2022;162:1035-1037.
PubMed
Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses
calling for early treatment with multiple checkpoint blockers.
Gut. 2022 May 4. pii: gutjnl-2021-326869. doi: 10.1136/gutjnl-2021-326869.
PubMed
Immunotherapy in hepatocellular carcinoma - No rush despite the hype.
Hepatology. 2022 May 1. doi: 10.1002/hep.32550.
PubMed
Comment on "Compromised hepatic mitochondrial fatty acid oxidation and reduced
markers of mitochondrial turnover in human NAFLD".
Hepatology. 2022 May 1. doi: 10.1002/hep.32551.
PubMed
Pharmaceutical Shp2 inhibition suppresses primary and metastasized liver tumors
by provoking hepatic innate immunity.
Hepatology. 2022 May 3. doi: 10.1002/hep.32555.
PubMed
Abstract available
Letter to Editor-Preliminary evidence of safety and tolerability of atezolizumab
plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B
cirrhosis: a real-world study- Should we extend the boundaries?
Hepatology. 2022 May 3. doi: 10.1002/hep.32554.
PubMed
Stromal yin-yang of myofibroblasts and endothelial cells in the progression of
intrahepatic cholangiocarcinoma.
Hepatology. 2022 May 3. doi: 10.1002/hep.32558.
PubMed
Primary Biliary Cholangitis: 2021 Practice Guidance Update from the American
Association for the Study of Liver Diseases.
Hepatology. 2021 Aug 24. doi: 10.1002/hep.32117.
PubMed
Abstract available
The RNA binding protein human antigen R is a gatekeeper of liver homeostasis.
Hepatology. 2022;75:881-897.
PubMed
Abstract available
DDX17-regulated alternative splicing that produced an oncogenic isoform of
PXN-AS1 to promote HCC metastasis.
Hepatology. 2022;75:847-865.
PubMed
Abstract available
Gut microbiome features associated with liver fibrosis in Hispanics, a population
at high risk for fatty liver disease.
Hepatology. 2022;75:955-967.
PubMed
Abstract available
Banff consensus recommendations for steatosis assessment in donor livers.
Hepatology. 2022;75:1014-1025.
PubMed
Abstract available
MT1 but not MT2 melatonin receptor knockout decreases biliary damage and liver
fibrosis during cholestatic liver injury.
Hepatology. 2021 Nov 7. doi: 10.1002/hep.32233.
PubMed
Abstract available
Determinants of the severity of fatty liver diseases: Need all the pieces to
solve the puzzle.
Hepatology. 2022;75:782-784.
PubMed
Letter to the editor: Serum thrombospondin-2 as biomarker in liver diseases, a
look beyond NASH.
Hepatology. 2022;75:1056-1057.
PubMed
Reply.
Hepatology. 2022;75:1066-1067.
PubMed
Reply.
Hepatology. 2022;75:1068-1069.
PubMed
Letter to the editor: Relevance of population-based cutoffs to define frailty in
clinical studies.
Hepatology. 2022;75:1067-1068.
PubMed
Baseline serum cystatin C as a marker of acute kidney injury in patients with
acute-on-chronic liver failure.
Indian J Gastroenterol. 2021;40:563-571.
PubMed
Abstract available
Combination of portal vein embolization and neoadjuvant chemotherapy for locally
advanced gallbladder cancer requiring extended hepatectomy - A novel approach.
Indian J Gastroenterol. 2021;40:580-589.
PubMed
Abstract available
Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic
fatty liver disease.
Indian J Gastroenterol. 2021;40:556-562.
PubMed
Abstract available
Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic
fatty liver disease and obesity.
Indian J Gastroenterol. 2021;40:572-579.
PubMed
Abstract available
Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic
inflammation in HBeAg-positive immune active patients.
J Gastroenterol Hepatol. 2022 May 4. doi: 10.1111/jgh.15881.
PubMed
Abstract available
Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic
target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].
J Hepatol. 2022 Apr 27. pii: S0168-8278(22)00240.
PubMed
Response to: Association of rectal colonization by mdros with new infection in
cirrhosis.
J Hepatol. 2022 Apr 30. pii: S0168-8278(22)00257.
PubMed
Reply to: "Evaluating sarcopenia in cirrhosis patients: the role of muscle
function".
J Hepatol. 2022 Apr 30. pii: S0168-8278(22)00259.
PubMed
LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
Oncogene. 2022 Feb 11. pii: 10.1038/s41388-022-02230.
PubMed
Abstract available
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma
progression by tuning TGF-beta signaling.
Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02334.
PubMed
Abstract available
Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells.
PLoS One. 2022;17:e0266966.
PubMed
Abstract available
Thrombocytosis and abnormal liver enzymes: A trigger for investigation of
underlying malignancy.
PLoS One. 2022;17:e0267124.
PubMed
Abstract available
Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular
carcinoma.
PLoS One. 2022;17:e0267117.
PubMed
Abstract available
Field evaluation of the enhanced MM3-COPRO ELISA test for the diagnosis of
Fasciola hepatica infection in sheep.
PLoS One. 2022;17:e0265569.
PubMed
Abstract available
Steatosis is involved in the progression of kidney disease in a
high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
PLoS One. 2022;17:e0265461.
PubMed
Abstract available
Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid
uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance.
PLoS One. 2022;17:e0265444.
PubMed
Abstract available
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular
carcinoma.
PLoS One. 2022;17:e0265235.
PubMed
Abstract available
Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal
cancer: A single-centre experience.
PLoS One. 2022;17:e0265093.
PubMed
Abstract available
Structural insights into the activation of autoinhibited human lipid flippase
ATP8B1 upon substrate binding.
Proc Natl Acad Sci U S A. 2022;119:e2118656119.
PubMed
Abstract available
The Role of Liver Zonation in Physiology, Regeneration, and Disease.
Semin Liver Dis. 2022;42:1-16.
PubMed
Abstract available
The Neglected Role of Bile Duct Epithelial Cells in NASH.
Semin Liver Dis. 2022;42:34-47.
PubMed
Abstract available
Liver Imaging Reporting and Data System: Review of Pros and Cons.
Semin Liver Dis. 2022;42:104-111.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by